Cencora, Inc.
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 15/3019% above fair value
$339.09−2.16 (-0.63%)
Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%
Cencora Option Care Health (OPCH) by Quarter
Option Care Health (OPCH) — Consolidated Gross Profit ($M) ($M)
Cencora Option Care Health (OPCH): $267M in Q3 FY26, down 0.6% from a year earlier.
Latest, Q3 FY26
267
Period ended Jun 30, 2026 (CQ2 2026)
Change on a year earlier
-0.6%
269 in Q3 FY25
History
64 quarters
Since Q4 FY08
Sources
1
SEC EDGAR XBRL CompanyFacts (OPCH)
Where the Q3 FY26 figure comes from
“OPCH us-gaap:GrossProfit = $267,251,000 (2026-04-01 to 2026-06-30)”
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Option Care Health (OPCH) — Consolidated Gross Profit ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 FY26CQ2 2026 | Jun 30, 2026 | 267 | -0.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY26CQ1 2026 | Mar 31, 2026 | 262 | -0.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY25CQ3 2025 | Sep 30, 2025 | 273 | +6.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY25CQ2 2025 | Jun 30, 2025 | 269 | +7.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY25CQ1 2025 | Mar 31, 2025 | 263 | +10.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY24CQ3 2024 | Sep 30, 2024 | 257 | +0.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY24CQ2 2024 | Jun 30, 2024 | 249 | -0.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY24CQ1 2024 | Mar 31, 2024 | 239 | +4.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY23CQ3 2023 | Sep 30, 2023 | 254 | +16.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY23CQ2 2023 | Jun 30, 2023 | 251 | +15.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY23CQ1 2023 | Mar 31, 2023 | 229 | +14.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY22CQ3 2022 | Sep 30, 2022 | 218 | +7.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY22CQ2 2022 | Jun 30, 2022 | 217 | +9.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY22CQ1 2022 | Mar 31, 2022 | 201 | +21.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY21CQ3 2021 | Sep 30, 2021 | 203 | +16.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY21CQ2 2021 | Jun 30, 2021 | 199 | +19.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY21CQ1 2021 | Mar 31, 2021 | 166 | +4.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY21CQ4 2020 | Dec 31, 2020 | 184 | +4.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY20CQ3 2020 | Sep 30, 2020 | 174 | +26.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY20CQ2 2020 | Jun 30, 2020 | 166 | +64.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY20CQ1 2020 | Mar 31, 2020 | 158 | +60.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY20CQ4 2019 | Dec 31, 2019 | 176 | +58.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY19CQ3 2019 | Sep 30, 2019 | 138 | +27.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY19CQ2 2019 | Jun 30, 2019 | 101 | +0.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY19CQ1 2019 | Mar 31, 2019 | 98.2 | -3.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY19CQ4 2018 | Dec 31, 2018 | 111 | +58.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY18CQ3 2018 | Sep 30, 2018 | 108 | +62.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY18CQ2 2018 | Jun 30, 2018 | 101 | +49.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY18CQ1 2018 | Mar 31, 2018 | 102 | +56.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY18CQ4 2017 | Dec 31, 2017 | 70.2 | -4.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY17CQ3 2017 | Sep 30, 2017 | 66.6 | +7.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY17CQ2 2017 | Jun 30, 2017 | 67.6 | +6.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY17CQ1 2017 | Mar 31, 2017 | 64.9 | +2.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY17CQ4 2016 | Dec 31, 2016 | 73.8 | +12.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY16CQ3 2016 | Sep 30, 2016 | 61.7 | -5.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY16CQ2 2016 | Jun 30, 2016 | 63.3 | -2.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY16CQ1 2016 | Mar 31, 2016 | 63.3 | -2.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY16CQ4 2015 | Dec 31, 2015 | 65.9 | +3.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY15CQ3 2015 | Sep 30, 2015 | 65.2 | +4.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY15CQ2 2015 | Jun 30, 2015 | 64.8 | +4.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY15CQ1 2015 | Mar 31, 2015 | 65 | +4.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY15CQ4 2014 | Dec 31, 2014 | 63.7 | -6.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY14CQ3 2014 | Sep 30, 2014 | 62.7 | +1.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY14CQ2 2014 | Jun 30, 2014 | 62.2 | +7.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY14CQ1 2014 | Mar 31, 2014 | 62.1 | +10.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY14CQ4 2013 | Dec 31, 2013 | 68.2 | +12.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY13CQ3 2013 | Sep 30, 2013 | 61.7 | +6.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY13CQ2 2013 | Jun 30, 2013 | 57.8 | +9.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY13CQ1 2013 | Mar 31, 2013 | 56 | +4.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY13CQ4 2012 | Dec 31, 2012 | 60.4 | +3.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY12CQ3 2012 | Sep 30, 2012 | 58 | +8.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY12CQ2 2012 | Jun 30, 2012 | 53 | +2.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY12CQ1 2012 | Mar 31, 2012 | 53.5 | +4.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY12CQ4 2011 | Dec 31, 2011 | 58.6 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY11CQ3 2011 | Sep 30, 2011 | 53.6 | -28.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY11CQ2 2011 | Jun 30, 2011 | 51.8 | -29.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY11CQ1 2011 | Mar 31, 2011 | 51.4 | +32.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY10CQ3 2010 | Sep 30, 2010 | 75.4 | +81.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY10CQ2 2010 | Jun 30, 2010 | 73.5 | +91.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY10CQ1 2010 | Mar 31, 2010 | 38.9 | +8.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY09CQ3 2009 | Sep 30, 2009 | 41.5 | +15.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY09CQ2 2009 | Jun 30, 2009 | 38.4 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY09CQ1 2009 | Mar 31, 2009 | 36 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY08CQ3 2008 | Sep 30, 2008 | 36.1 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
Cite this data
StockData. (2026). Cencora Option Care Health (OPCH) ($M), quarterly Q4 FY08–Q3 FY26 [Data set]. Compiled from Cencora SEC filings and investor materials. https://stockdatahq.com/stocks/cor/kpis/peer-opch-gp
See every metric in the Cencora KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?